Literature DB >> 530307

The regional localization of R28935 in the cat brain as dependent on the route of administration.

A J Loonen, W Soudijn, H H van Rooij, I V Wijngaarden.   

Abstract

Intravenous injection of the antihypertensive agent R2835 and its pharmacologically less active threo-isomer R29814 resulted in a distribution profile in the cat brain which differed from the regional localization after administration via the left vertebral artery. Although the two isomers had the same physico-chemical properties, R28935 penetrated more readily into the CNS. Intravenous administration resulted in almost equal levels in all brain parts, whereas after injection into the vertebral artery caudal structures contained more of both compounds that rostral structures. Differences existed between the concentrations in homotopic brain areas, especially in the brain stem. From comparison of the levels of R28935 after injection of an equiactive dose either i.v. or into the vertebral artery it is tempting to speculate that the mesencephalic tegmentum, the nucleus of the solitary tract, the inferior colliculi and/or the locus coeruleus are possible sites of the hypotensive action.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 530307     DOI: 10.1007/BF00504761

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  11 in total

1.  A centrally acting antihypertensive agent (R28935) not mediated via central alpha-adrenoreceptors.

Authors:  L Finch
Journal:  Eur J Pharmacol       Date:  1975 Sep-Oct       Impact factor: 4.432

2.  R 28935 and prazosin: effects on central and peripheral alpha-adrenoreceptor activity and on blood pressure.

Authors:  N E Andén; C Gomes; B Persson; G Trolin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-05       Impact factor: 3.000

3.  The regional localisation of a new potent centrally acting antihypertensive agent R 28935 and its less active threo-isomer R29814 in the cat brain.

Authors:  A J Loonen; W Soudijn; H H Van Rooy; I Van Wijngaarden
Journal:  Eur J Pharmacol       Date:  1977-10-01       Impact factor: 4.432

4.  Central hypotensive effect of alpha-methyldopa.

Authors:  M Henning; P A van Zwieten
Journal:  J Pharm Pharmacol       Date:  1968-06       Impact factor: 3.765

5.  Acute hypotensive action of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155) after infusion into the cat's vertebral artery.

Authors:  R W Sattler; P A van Zwieten
Journal:  Eur J Pharmacol       Date:  1967-10       Impact factor: 4.432

6.  A benzodioxanhydroxyethylpiperidine derivative with an acute central hypotensive action, different from that of clonidine. A comparison with neuroleptic agents.

Authors:  P A Van Zwieten
Journal:  Arch Int Pharmacodyn Ther       Date:  1975-05

7.  Antihypertensive activity of erythro-1-(1-[2-(1,4-benzodioxan-2-yl)-2-OH-ET]-4-piperidyl)-2-benzimidazolinone (R 28935).

Authors:  D Wellens; L Snoeckx; R De Reese; R Kruger; A Van de Water; L Woutens; R S Reneman
Journal:  Arch Int Pharmacodyn Ther       Date:  1975-05

8.  Unusual mechanism of hypotensive activity exerted by erytrho-1-(1-[2-(1,4-benzodioxan-2-yl)-2-OH-ET-a1-4-piperidyl)-2-benzimidazolinone (R 28935).

Authors:  D Wellens; A De Wilde; A van Bogaert; P P van Bogaert; L Wouters; R S Reneman; P A Janssen
Journal:  Arch Int Pharmacodyn Ther       Date:  1975-05

9.  The cerebral blood distribution in dogs and cats. An anatomical and functional study.

Authors:  D L Wellens; L J Wouters; R J De Reese; P Beirnaert; R S Reneman
Journal:  Brain Res       Date:  1975-03-28       Impact factor: 3.252

10.  Effects of R-28935 on sympathetic nervous activity in anesthetized cat.

Authors:  D G Taylor; M J Antonaccio
Journal:  Clin Exp Hypertens       Date:  1978       Impact factor: 1.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.